Double blind comparison of ioglicate and iothalamate in intravenous urography

[Value of digital subtraction angiography in the imaging of a subcutaneously implanted, intra-arterial chemotherapy catheter].

Digitale Bilddiagnostik·1986

[Value of intra-arterial digital subtraction angiography].

Der Radiologe·1986

Contrast media and pain in peripheral arteriography.

Investigative radiology·1980

[Correlation of growth-phase and streptodornase-production of beta-hemolytic streptococci group A (author's transl)].

Immunitat und Infektion·1978

[Hemangioma of the renal pelvis (author's transl)].

Der Radiologe·1978

[Therapeutic vascular occlusion with angiographic catheter technique (author's transl)].

Der Radiologe·1977

Renal and hepatic tolerance of nonionic and ionic contrast media in intravenous digital subtraction angiography.

Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband·1989

Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients.

Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband·1989

Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs.

Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband·1989

Experimental urography in dogs: diagnostic quality and pharmacokinetic behavior of iotrolan in comparison to nonionic and ionic, monomeric contrast media.

Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband·1989

Coronary arteriography with iotrolan 280, a blood-isotonic, nonionic, dimeric contrast medium: preliminary clinical results.

Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband·1989

Controlled, double-blind study of iosimide, a new, nonionic, monomeric contrast medium, and ioxaglate in cerebral angiography.

Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband·1989

Targeted Intracranial Delivery of Secreted Immune Molecules to Investigate Neuroimmune Interactions.

Journal of visualized experiments : JoVE·2026

Pilot study of Wilms tumor 1-targeted human platelet lysate-induced antigen-presenting cells in advanced solid cancer patients.

Regenerative therapy·2026

Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications.

Regenerative therapy·2026

Beyond immune suppression: regenerative programs in regulatory T cells.

Cell insight·2026

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

BMJ neurology open·2026

DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

Antibody therapeutics·2026

Related Experiment Videos

Double blind comparison of ioglicate and iothalamate in intravenous urography

Related Concept Videos

[Value of digital subtraction angiography in the imaging of a subcutaneously implanted, intra-arterial chemotherapy catheter].

[Value of intra-arterial digital subtraction angiography].

Contrast media and pain in peripheral arteriography.

[Correlation of growth-phase and streptodornase-production of beta-hemolytic streptococci group A (author's transl)].

[Hemangioma of the renal pelvis (author's transl)].

[Therapeutic vascular occlusion with angiographic catheter technique (author's transl)].

Renal and hepatic tolerance of nonionic and ionic contrast media in intravenous digital subtraction angiography.

Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients.

Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs.

Experimental urography in dogs: diagnostic quality and pharmacokinetic behavior of iotrolan in comparison to nonionic and ionic, monomeric contrast media.

Coronary arteriography with iotrolan 280, a blood-isotonic, nonionic, dimeric contrast medium: preliminary clinical results.

Controlled, double-blind study of iosimide, a new, nonionic, monomeric contrast medium, and ioxaglate in cerebral angiography.

Targeted Intracranial Delivery of Secreted Immune Molecules to Investigate Neuroimmune Interactions.

Pilot study of Wilms tumor 1-targeted human platelet lysate-induced antigen-presenting cells in advanced solid cancer patients.

Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications.

Beyond immune suppression: regenerative programs in regulatory T cells.

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

Related Experiment Videos

Double blind comparison of ioglicate and iothalamate in intravenous urography

Related Concept Videos

Related Articles